Literature DB >> 31837262

Reply to Watt.

Tri Wangrangsimakul1,2, Weerawat Phuklia3, Paul N Newton1,2,3, Allen L Richards4, Nicholas P J Day1,2.   

Abstract

Entities:  

Year:  2020        PMID: 31837262      PMCID: PMC7486835          DOI: 10.1093/cid/ciz1192

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
To the Editor—We thank the author for his letter [1]. At the heart of the debate is the issue of how antibiotic resistance for Orientia species should be defined. We applied strictly microbiological criteria to doxycycline resistance, based on minimum inhibitory concentrations (MICs) and the pharmacokinetic/pharmacodynamic (PK/PD) properties of the tested antibiotics [2]. Doxycycline MICs obtained for AFC-3 and AFSC-4 Orientia tsutsugamushi isolates were recently reported at 0.125 mg/L and 0.250 mg/L, respectively [3]. These values fall within the expected wild-type distribution of doxycycline MICs (median of 0.125 mg/L ± one to two 2-fold dilution steps) in 5 reference strains (including Karp and Gilliam, prototypical strains considered doxycycline susceptible) and 51 clinical isolates from Laos and Thailand, and remain well below the plasma concentrations achieved in humans at standard doses (100–200 mg/day, peak serum concentrations of 1.7–5.9 mg/L) [3-5]. The small differences between doxycycline MICs observed are likely due to technical variation rather than major differences in susceptibility. The author stipulates that attenuated clinical response to doxycycline implies diminished susceptibility and dismisses other important factors known to influence infection such as bacterial virulence and host immunity [1]. We do not dispute that some scrub typhus patients in Chiangrai have prolonged fever clearance times despite appropriate antibiotic treatment. However, fever clearance times ≥72 hours were observed in some patients receiving doxycycline, rifampicin, azithromycin, and chloramphenicol as part of clinical trials conducted in Thailand and in South Korea [6-10]. Results of the mouse survivability assay may be influenced by virulence of the infecting O. tsutsugamushi isolates [11]. The differences in pharmacokinetics of antibiotics in mice and lack of comparison to other reference and clinical isolates from patients with appropriate responses to treatment are additional weaknesses [12, 13]. The author’s work shows that mouse survivability rates were similar for doxycycline and azithromycin when infected with Chiangrai O. tsutsugamushi isolates [14]. If diminished antibiotic susceptibility is determined by attenuated clinical response and reduced mouse survivability, then resistance in scrub typhus to the main antibiotics used appear widespread. Current evidence suggests that other factors described in our article influence clinical response and that a microbiological basis for doxycycline resistance in O. tsutsugamushi is lacking. Chiangrai patients from the author’s original study were on average febrile for longer prior to admission than patients from Mae Sot [13]. Although statistical significance was not reached, the differences may have potentially affected outcome, and larger studies to assess the relationship between age and duration of fever to outcome are required. We referenced the author’s work while discussing potential sources of antibiotic selective pressure. There is evidence for the widespread use of antibiotics in animal feed globally and in Thailand, but we agree that detailed comparative studies at the provincial level are unavailable [15-18]. We believe that antibiotic susceptibility for O. tsutsugamushi should be based on MICs and PK/PD data and advocate the use of antimicrobial susceptibility tests that are accurate and reproducible, allowing for standardization and harmonization of results. Current trials embedding analysis of these important aspects should provide further clarity.
  17 in total

1.  Drug-resistant scrub typhus: Paradigm and paradox.

Authors:  R Rosenberg
Journal:  Parasitol Today       Date:  1997-04

2.  Global trends in antimicrobial use in food animals.

Authors:  Thomas P Van Boeckel; Charles Brower; Marius Gilbert; Bryan T Grenfell; Simon A Levin; Timothy P Robinson; Aude Teillant; Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-19       Impact factor: 11.205

Review 3.  Clinical pharmacokinetics of doxycycline and minocycline.

Authors:  S Saivin; G Houin
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

4.  Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand.

Authors:  G Watt; P Kantipong; K Jongsakul; P Watcharapichat; D Phulsuksombati
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Drug-Resistant Scrub Typhus.

Authors:  George Watt
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

6.  Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: a randomised trial.

Authors:  G Watt; P Kantipong; K Jongsakul; P Watcharapichat; D Phulsuksombati; D Strickman
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

7.  Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus.

Authors:  Kriangsak Phimda; Siriwan Hoontrakul; Chuanpit Suttinont; Sompong Chareonwat; Kitti Losuwanaluk; Sunee Chueasuwanchai; Wirongrong Chierakul; Duangjai Suwancharoen; Saowaluk Silpasakorn; Watcharee Saisongkorh; Sharon J Peacock; Nicholas P J Day; Yupin Suputtamongkol
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

Review 8.  Antibiotic distribution channels in Thailand: results of key-informant interviews, reviews of drug regulations and database searches.

Authors:  Angkana Sommanustweechai; Sunicha Chanvatik; Varavoot Sermsinsiri; Somsajee Sivilaikul; Walaiporn Patcharanarumol; Shunmay Yeung; Viroj Tangcharoensathien
Journal:  Bull World Health Organ       Date:  2018-01-02       Impact factor: 9.408

Review 9.  Scrub Typhus and the Misconception of Doxycycline Resistance.

Authors:  Tri Wangrangsimakul; Weerawat Phuklia; Paul N Newton; Allen L Richards; Nicholas P J Day
Journal:  Clin Infect Dis       Date:  2020-05-23       Impact factor: 9.079

10.  Novel high-throughput screening method using quantitative PCR to determine the antimicrobial susceptibility of Orientia tsutsugamushi clinical isolates.

Authors:  Weerawat Phuklia; Phonepasith Panyanivong; Davanh Sengdetka; Piengchan Sonthayanon; Paul N Newton; Daniel H Paris; Nicholas P J Day; Sabine Dittrich
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

View more
  1 in total

1.  Genome-Wide Association Study Identifies Eight Novel Loci for Susceptibility of Scrub Typhus and Highlights Immune-Related Signaling Pathways in Its Pathogenesis.

Authors:  Yong-Chan Kim; Soriul Kim; Hee-Kwon Kim; Yi Lee; Chol Shin; Chang-Seop Lee; Byung-Hoon Jeong
Journal:  Cells       Date:  2021-03-05       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.